Application of the Colon-Simulation Technique for Studying the Effects of Saccharomyces boulardii on Basic Parameters of Porcine Cecal Microbial Metabolism Disturbed by Clindamycin

Aims: The present study analyzed the effects of Saccharomyces boulardii on the biochemical parameters of microbial hindgut metabolism disturbed by clindamycin. Methods: The experiments were carried out under in vitro conditions using the semicontinuous colon-simulation technique. This technique is standardized for quantitatively measuring parameters of microbial hindgut metabolism. The fluid and particle phase of pig hindgut contents were used for the in vitro incubations. The 5-day control period was followed by clindamycin exposure alone (312.5 mg/day for 5 days) or by a combined treatment of clindamycin and S. boulardii (400 mg/day for 5 days). Results: Clindamycin resulted in significant decreases in production rates of short-chain fatty acids (SCFAs) which were associated with substantial changes in molar SCFA proportions at the expense of butyrate. These effects could at least partly be compensated for by S. boulardii, in particular by enhancements of acetate and propionate fermentation to control levels. In contrast, butyrate fermentation could not be reconstituted. In a second experiment the potential use of S. boulardii as a substrate for hindgut microbial metabolism was studied by comparing living and autoclaved yeast. Propionate and butyrate fermentation rates were unaffected whereas acetate fermentation tended to be higher in the presence of living yeast. Conclusions: S. boulardii can be effective to compensate for changes in microbial fermentation in response to antibiotic treatment. Despite the lack of statistical significance it might be concluded that the increase in fermentation end products can only partly be explained by the utilization of the yeast as a substrate for microbial metabolism.

[1]  C. Pothoulakis,et al.  Pathogenesis of Clostridium difficile-associated diarrhoea. , 1996, European journal of gastroenterology & hepatology.

[2]  W. Graninger,et al.  Comparison of vancomycin, teicoplanin, metronidazole, and fusidic acid for the treatment of Clostridium difficile-associated diarrhea. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  G. Breves,et al.  The application of a semi-continuous colon simulation technique (Cositec) for studying the effects of clindamycin on microbial hindgut metabolism. , 1995, Zeitschrift für Gastroenterologie - German Journal of Gastroenterology.

[4]  C. Surawicz,et al.  Prevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo. , 1995, The American journal of gastroenterology.

[5]  J. Buts,et al.  Saccharomyces boulardii Enhances Rat Intestinal Enzyme Expression by Endoluminal Release of Polyamines , 1994, Pediatric Research.

[6]  C. Surawicz,et al.  A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. , 1994, JAMA.

[7]  A. Glatt,et al.  Epidemiology, clinical manifestations, and outcome of Clostridium difficile-associated diarrhea. , 1994, The American journal of gastroenterology.

[8]  P. Mortensen,et al.  Faecal DL-lactate concentration in 100 gastrointestinal patients. , 1994, Scandinavian journal of gastroenterology.

[9]  C. Pothoulakis,et al.  Clostridium difficile colitis and diarrhea. , 1993, Gastroenterology clinics of North America.

[10]  C. Pothoulakis,et al.  Saccharomyces boulardii inhibits Clostridium difficile toxin A binding and enterotoxicity in rat ileum. , 1993, Gastroenterology.

[11]  T. Kirchner,et al.  Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. , 1992, Gastroenterology.

[12]  P. Mortensen,et al.  Fermentation to short-chain fatty acids and lactate in human faecal batch cultures. Intra- and inter-individual variations versus variations caused by changes in fermented saccharides. , 1991, Scandinavian journal of gastroenterology.

[13]  C. Surawicz,et al.  Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients. , 1990, The Journal of infectious diseases.

[14]  J. Hotz [Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii: a prospective study]. , 1990, Zeitschrift fur Gastroenterologie.

[15]  C. Surawicz,et al.  Treatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii. , 1989, The American journal of gastroenterology.

[16]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[17]  C. M. Wood,et al.  Treatment of diversion colitis with short-chain-fatty acid irrigation. , 1989, The New England journal of medicine.

[18]  R. Caprilli,et al.  Fecal lactate and ulcerative colitis. , 1988, Gastroenterology.

[19]  N. Read,et al.  Effect of clindamycin on the ability of a continuous culture of colonic bacteria to ferment carbohydrate. , 1986, Gut.

[20]  D. Gordon,et al.  Antibiotic-associated colitis due to Clostridium difficile: double-blind comparison of vancomycin with bacitracin. , 1985, Gastroenterology.

[21]  R. Möllby,et al.  Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982. , 1985, The Journal of infectious diseases.

[22]  D. Gerding,et al.  PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITIS , 1983, The Lancet.

[23]  J. Greenhalgh Nutritional limits to animal production from pastures , 1983 .

[24]  W. Roediger Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. , 1980, Gut.

[25]  J. Czerkawski,et al.  Design and development of a long-term rumen simulation technique (Rusitec) , 1977, British Journal of Nutrition.

[26]  M. Becker,et al.  Grundzüge der Fütterungslehre , 1909 .

[27]  W. E. W. ROEDlGER Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man , 2006 .